Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Randomized, Comparative, Multicenter Study in Parallel Groups of the Efficacy, Safety, Immunogenicity of Etanercept and Enbrel, Lyophilisates for Solution for Subcutaneous Injection, in Patients With Rheumatoid Arthritis

NCT04079374 is registered in ClinicalTrials.gov with Joint Stock Company "Farmak" as lead sponsor.

NCT NCT04079374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04079374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Randomized, Comparative, Multicenter Study in Parallel Groups of the Efficacy, Safety, Immunogenicity of Etanercept and Enbrel, Lyophilisates for Solution for Subcutaneous Injection, in Patients With Rheumatoid Arthritis
Lead sponsor
Joint Stock Company "Farmak"
Phase
Phase 3
Overall status
Unknown status
Start date
September 3, 2018
Completion date
December 3, 2023
Enrollment
160 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis